Suchergebnisse - "Moser, Stephan"

PubPharm (4)

1

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19 : A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

enthalten in: Trials | 2021

von Urwyler, P. | Charitos, P. | Moser, S. | +11

2

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury

enthalten in: JACC. Cardiovascular interventions | 2020

von Panagiotou, A. | Trendelenburg, M. | Heijnen, I. | +7

CommentIn: JACC Cardiovasc Interv. 2020 Apr 13;13(7):843-845. - PMID 32171716

3

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

enthalten in: Frontiers in immunology | 2020

von Urwyler, P. | Moser, S. | Charitos, P. | +8

4

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study

enthalten in: Wiener klinische Wochenschrift | 2018

von Gschwantler, M. | Laferl, H. | Vogel, W. | +11

1
[1]